As of June 20, 2025, Itamar Medical Ltd (ITMR.TA) reports a ROE (Return on Equity) of -25.40%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Itamar Medical Ltd's ROE (Return on Equity)
Over recent years, Itamar Medical Ltd's ROE (Return on Equity) has shown a stable trend. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2020-12-31 | -25.40% |
| 2019-12-31 | -31.61% |
| 2018-12-31 | -25.85% |
| 2017-12-31 | -384.97% |
| 2016-12-31 | -274.81% |
This slight downward trend highlights how Itamar Medical Ltd manages its efficiency in generating profits from shareholders' equity over time.
Comparing Itamar Medical Ltd's ROE (Return on Equity) to Peers
To better understand Itamar Medical Ltd's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Itamar Medical Ltd (ITMR.TA) | -25.40% |
| Elbit Medical Technologies Ltd (EMTC.TA) | 267.15% |
| Beijing Chunlizhengda Medical Instruments Co Ltd (1858.HK) | 26.25% |
| Shenzhen Lifotronic Technology Co Ltd (688389.SS) | 16.84% |
| Dentium Co Ltd (145720.KS) | 13.11% |
| iRay Technology Co Ltd (688301.SS) | 10.03% |
Compared to its competitors, Itamar Medical Ltd's ROE (Return on Equity) is among the lowest compared to peers, which may indicate less effective deployment of shareholders' capital.